EP0575518A1
(en)
|
1991-03-06 |
1993-12-29 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the selective inhibition of gene expression
|
US6410010B1
(en)
|
1992-10-13 |
2002-06-25 |
Board Of Regents, The University Of Texas System |
Recombinant P53 adenovirus compositions
|
US5747469A
(en)
*
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
ATE322547T1
(de)
*
|
1993-06-10 |
2006-04-15 |
Genetic Therapy Inc |
Adenovirale vektoren für die behandlung der hämophilie
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
US5851806A
(en)
*
|
1994-06-10 |
1998-12-22 |
Genvec, Inc. |
Complementary adenoviral systems and cell lines
|
EP1548118A2
(en)
|
1994-06-10 |
2005-06-29 |
Genvec, Inc. |
Complementary adenoviral vector systems and cell lines
|
AU711269B2
(en)
*
|
1994-08-16 |
1999-10-07 |
Crucell Holland B.V. |
Recombinant vectors derived from adenovirus for use in gene therapy
|
FR2723697B1
(fr)
*
|
1994-08-17 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Methode de traitement de la restenose par la therapie genique
|
US5856152A
(en)
*
|
1994-10-28 |
1999-01-05 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV vector and methods of use therefor
|
EP0787200B1
(en)
|
1994-10-28 |
2005-04-20 |
The Trustees Of The University Of Pennsylvania |
Improved adenovirus and methods of use thereof
|
FR2727867B1
(fr)
|
1994-12-13 |
1997-01-31 |
Rhone Poulenc Rorer Sa |
Transfert de genes dans les motoneurones medullaires au moyen de vecteurs adenoviraux
|
FR2741891B1
(fr)
*
|
1995-06-01 |
1998-01-09 |
Centre Nat Rech Scient |
Cellules pour la production d'adenovirus recombinants
|
IL116816A
(en)
*
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
FR2729674B1
(fr)
*
|
1995-01-20 |
1997-04-11 |
Centre Nat Rech Scient |
Cellules pour la production d'adenovirus recombinants
|
FR2738575B1
(fr)
*
|
1995-09-08 |
1997-10-10 |
Centre Nat Rech Scient |
Cellules pour la production d'adenovirus recombinants
|
FR2730504B1
(fr)
*
|
1995-02-13 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Procede de preparation de genomes d'adenovirus recombinants
|
US5637456A
(en)
*
|
1995-02-17 |
1997-06-10 |
The University Of Texas, Board Of Regents |
Rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation
|
US5652224A
(en)
|
1995-02-24 |
1997-07-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
|
US6752987B1
(en)
|
1995-02-28 |
2004-06-22 |
The Regents Of The University Of California |
Adenovirus encoding human adenylylcyclase (AC) VI
|
EP0760682A4
(en)
|
1995-02-28 |
1998-09-09 |
Univ California |
ANGIOGENIC THERAPY BY GENE TRANSFER
|
FR2731710B1
(fr)
*
|
1995-03-14 |
1997-04-30 |
Rhone Poulenc Rorer Sa |
Virus recombinants exprimant la lecithine cholesterol acyltransferase et utilisations en therapie genique
|
JP3770333B2
(ja)
*
|
1995-03-15 |
2006-04-26 |
大日本住友製薬株式会社 |
組換えdnaウイルスおよびその製造方法
|
US5707618A
(en)
*
|
1995-03-24 |
1998-01-13 |
Genzyme Corporation |
Adenovirus vectors for gene therapy
|
FR2732357B1
(fr)
*
|
1995-03-31 |
1997-04-30 |
Rhone Poulenc Rorer Sa |
Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose
|
WO1996033280A1
(en)
*
|
1995-04-17 |
1996-10-24 |
Board Of Regents, The University Of Texas System |
An adenovirus helper-virus system
|
FR2734826B1
(fr)
*
|
1995-06-01 |
1997-07-04 |
Rhone Poulenc Rorer Sa |
Deltap62, ses variants, sequences nucleiques et leurs utilisations
|
US6281010B1
(en)
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
AU6261696A
(en)
|
1995-06-05 |
1996-12-24 |
Trustees Of The University Of Pennsylvania, The |
A replication-defective adenovirus human type 5 recombinant as a vaccine carrier
|
US5756283A
(en)
*
|
1995-06-05 |
1998-05-26 |
The Trustees Of The University Of Pennsylvania |
Method for improved production of recombinant adeno-associated viruses for gene therapy
|
US5698202A
(en)
*
|
1995-06-05 |
1997-12-16 |
The Wistar Institute Of Anatomy & Biology |
Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier
|
US6265212B1
(en)
|
1995-06-15 |
2001-07-24 |
Introgene B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
US6783980B2
(en)
|
1995-06-15 |
2004-08-31 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
DE69638058D1
(de)
|
1995-06-15 |
2009-11-26 |
Crucell Holland Bv |
Verpackungssysteme für humane rekombinante Adenoviren zur Gentherapie
|
AU6390596A
(en)
*
|
1995-06-23 |
1997-01-22 |
Board Of Regents, The University Of Texas System |
C-cam expression constructs and their application in cancer therapy
|
FR2735789B1
(fr)
*
|
1995-06-23 |
1997-07-25 |
Centre Nat Rech Scient |
Adenovirus recombinants, leur utilisation pour preparer des aav, lignee cellulaire complementaire et compositions pharmaceutiques les contenant
|
FR2737222B1
(fr)
|
1995-07-24 |
1997-10-17 |
Transgene Sa |
Nouveaux vecteurs viraux et lignee pour la therapie genique
|
FR2737221B1
(fr)
*
|
1995-07-24 |
1997-10-17 |
Transgene Sa |
Nouveaux vecteurs viraux pour la therapie genique
|
AUPN477695A0
(en)
*
|
1995-08-14 |
1995-09-07 |
Commonwealth Scientific And Industrial Research Organisation |
Gene therapy
|
US6482803B1
(en)
|
1995-09-01 |
2002-11-19 |
Board Of Regents, The University Of Texas System |
Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A
|
WO1997016547A1
(en)
*
|
1995-10-31 |
1997-05-09 |
The Board Of Regents, The University Of Texas System |
ADENOVIRUS-ANTISENSE K-ras EXPRESSION VECTORS AND THEIR APPLICATION IN CANCER THERAPY
|
JP2006075171A
(ja)
*
|
1995-11-09 |
2006-03-23 |
Avigen Inc |
組換えaavビリオン産生における使用のための補助機能
|
US6004797A
(en)
*
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
WO1997017937A2
(de)
*
|
1995-11-17 |
1997-05-22 |
Franz Wolfgang M |
Gentherapeutisches nukleinsäurekonstrukt, seine herstellung und verwendung zur behandlung von herzerkrankungen
|
FR2746110B1
(fr)
*
|
1996-03-14 |
1998-04-17 |
|
Methode de traitement par therapie genique des tumeurs humaines et virus recombinants correspondants
|
US6132989A
(en)
*
|
1996-06-03 |
2000-10-17 |
University Of Washington |
Methods and compositions for enhanced stability of non-adenoviral DNA
|
US20040156861A1
(en)
|
1996-07-11 |
2004-08-12 |
Figdor Carl Gustav |
Melanoma associated peptide analogues and vaccines against melanoma
|
US5958892A
(en)
|
1996-07-30 |
1999-09-28 |
Board Of Regents, The University Of Texas System |
2-methoxyestradiol-induced apoptosis in cancer cells
|
US6083716A
(en)
*
|
1996-09-06 |
2000-07-04 |
The Trustees Of The University Of Pennsylvania |
Chimpanzee adenovirus vectors
|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
CA2266342C
(en)
*
|
1996-09-25 |
2010-06-08 |
Novartis Ag |
Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
KR100516561B1
(ko)
|
1996-12-06 |
2005-09-22 |
아벤티스 파마슈티칼스 인크. |
사람 리파제-유사 유전자에 의해 암호화된 폴리펩타이드, 조성물 및 방법
|
US7008776B1
(en)
|
1996-12-06 |
2006-03-07 |
Aventis Pharmaceuticals Inc. |
Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
|
WO1998032860A1
(en)
*
|
1997-01-28 |
1998-07-30 |
Baxter International Inc. |
Methods for highly efficient generation of adenoviral vectors
|
US6403370B1
(en)
|
1997-02-10 |
2002-06-11 |
Genstar Therapeutics Corporation |
Oncolytic/immunogenic complementary-adenoviral vector system
|
PL336523A1
(en)
|
1997-04-28 |
2000-07-03 |
Rhone Poulenc Rorer Sa |
Intraneoplastic delivery of an angiogenesis antagonist by means of adenoviruses in order to treat neoplasms
|
AUPO856097A0
(en)
|
1997-08-14 |
1997-09-04 |
Commonwealth Scientific And Industrial Research Organisation |
Vector
|
US6251677B1
(en)
|
1997-08-25 |
2001-06-26 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
US6875606B1
(en)
|
1997-10-23 |
2005-04-05 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Human α-7 nicotinic receptor promoter
|
US6653088B1
(en)
|
1997-10-24 |
2003-11-25 |
Aventis Pharma S.A. |
Interaction test for the investigation of inhibitory molecules of the interaction between a presenilin and the β-amyloid peptide
|
CN1263854C
(zh)
|
1997-11-06 |
2006-07-12 |
启龙股份公司 |
奈瑟球菌抗原
|
DE69926729T2
(de)
|
1998-01-08 |
2006-06-08 |
Aventis Pharmaceuticals Inc. |
Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert
|
WO1999036544A2
(en)
|
1998-01-14 |
1999-07-22 |
Chiron S.P.A. |
Neisseria meningitidis antigens
|
US6670188B1
(en)
|
1998-04-24 |
2003-12-30 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
EP1645631B1
(en)
|
1998-05-01 |
2007-10-24 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria antigens and compositions
|
US6225456B1
(en)
|
1998-05-07 |
2001-05-01 |
University Technololy Corporation |
Ras suppressor SUR-5
|
US6506889B1
(en)
|
1998-05-19 |
2003-01-14 |
University Technology Corporation |
Ras suppressor SUR-8 and related compositions and methods
|
US6413776B1
(en)
|
1998-06-12 |
2002-07-02 |
Galapagos Geonomics N.V. |
High throughput screening of gene function using adenoviral libraries for functional genomics applications
|
WO2000012740A2
(en)
*
|
1998-08-28 |
2000-03-09 |
Duke University |
ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES
|
US6441156B1
(en)
|
1998-12-30 |
2002-08-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Calcium channel compositions and methods of use thereof
|
US6387368B1
(en)
|
1999-02-08 |
2002-05-14 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
US6291226B1
(en)
*
|
1999-02-25 |
2001-09-18 |
National Research Council Of Canada |
Adenovirus mutants with deleted protease gene
|
SI1533380T1
(sl)
*
|
1999-04-15 |
2010-03-31 |
Crucell Holland Bv |
Proizvajanje rekombinantnega proteina v človeški celici ki obsega vsaj en protein E adenovirusa
|
WO2000066741A2
(en)
|
1999-04-30 |
2000-11-09 |
Chiron S.P.A. |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US6793926B1
(en)
|
1999-05-27 |
2004-09-21 |
Genovo, Inc. |
Methods for production of a recombinant adeno-associated virus
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
FR2799472B1
(fr)
|
1999-10-07 |
2004-07-16 |
Aventis Pharma Sa |
Preparation d'adenovirus recombinants et de banques adenovirales
|
PT2275551E
(pt)
|
1999-10-29 |
2015-06-29 |
Novartis Vaccines & Diagnostic |
Péptidos antigénicos de neisseria
|
WO2001048164A2
(en)
|
1999-12-27 |
2001-07-05 |
The Regents Of The University Of California |
Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure
|
MXPA02006962A
(es)
|
2000-01-17 |
2002-12-13 |
Chiron Spa |
Vacuna de vesicula de membrana exterior que comprende proteinas de membrana exterior de neisseria meningitidis serogrupo b.
|
JP4750999B2
(ja)
|
2000-03-31 |
2011-08-17 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
核因子κB誘導因子
|
GB0018307D0
(en)
|
2000-07-26 |
2000-09-13 |
Aventis Pharm Prod Inc |
Polypeptides
|
US7125549B2
(en)
*
|
2000-05-31 |
2006-10-24 |
Human Gene Therapy Research Institute |
Methods and compositions for efficient gene transfer using transcomplementary vectors
|
CA2881568C
(en)
|
2000-10-27 |
2019-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from streptococcus groups a & b
|
US7060442B2
(en)
|
2000-10-30 |
2006-06-13 |
Regents Of The University Of Michigan |
Modulators on Nod2 signaling
|
US7118756B2
(en)
|
2000-12-28 |
2006-10-10 |
Wyeth |
Recombinant protective protein from Streptococcus pneumoniae
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
AUPR518501A0
(en)
|
2001-05-22 |
2001-06-14 |
Unisearch Limited |
Yin yang-1
|
US6682929B2
(en)
|
2001-07-23 |
2004-01-27 |
Genvec, Inc. |
Adenovector complementing cells
|
US7569217B2
(en)
|
2001-09-24 |
2009-08-04 |
University Of Saskatchewan |
Porcine adenovirus E1 and E4 regions
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
EP2335724A1
(en)
|
2001-12-12 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisation against chlamydia trachomatis
|
RU2004125283A
(ru)
*
|
2002-01-18 |
2005-06-10 |
Шеринг Акциенгезельшафт (De) |
Стабилизированные композиции аденовируса
|
US7319001B2
(en)
|
2002-03-09 |
2008-01-15 |
Neurogenex Co., Ltd. |
High throughput system for producing recombinant viruses using site-specific recombination
|
NZ571508A
(en)
|
2002-05-24 |
2010-05-28 |
Schering Corp |
Neutralizing human anti-IGFR antibody
|
US7977049B2
(en)
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
CA2421269A1
(en)
|
2002-08-09 |
2004-02-09 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
RU2244928C2
(ru)
*
|
2003-02-19 |
2005-01-20 |
Пинигина Нина Максимовна |
Эндогенная фармацевтическая композиция, полученная на основе целенаправленной активации гуморальных медиаторов нервных окончаний коры головного мозга
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
EP1649028B1
(en)
*
|
2003-07-25 |
2012-08-22 |
Genvec, Inc. |
Adenoviral vector-based vaccines
|
WO2005051432A1
(en)
|
2003-11-14 |
2005-06-09 |
Genvec, Inc. |
Therapeutic regimen for treating cancer
|
US7432057B2
(en)
|
2004-01-30 |
2008-10-07 |
Michigan State University |
Genetic test for PSE-susceptible turkeys
|
KR101222281B1
(ko)
|
2004-03-29 |
2013-01-28 |
가르파마 컴퍼니 리미티드 |
신규 갈렉틴 9 개변체 단백질 및 그 용도
|
AU2005243730B2
(en)
|
2004-04-12 |
2010-05-27 |
Genvec, Inc. |
Method of using adenoviral vectors to induce an immune response
|
KR101169109B1
(ko)
|
2004-05-26 |
2012-07-26 |
싸이오서스 테라퓨틱스 엘티디. |
암 치료에 사용하기 위한 키메릭 아데노바이러스
|
CN101087879B
(zh)
|
2004-06-18 |
2013-08-14 |
杜克大学 |
气味受体的调控剂
|
US7604798B2
(en)
|
2004-07-15 |
2009-10-20 |
Northwestern University |
Methods and compositions for importing nucleic acids into cell nuclei
|
AU2005274948B2
(en)
|
2004-07-16 |
2011-09-22 |
Genvec, Inc. |
Vaccines against aids comprising CMV/R-nucleic acid constructs
|
WO2006039045A2
(en)
*
|
2004-09-01 |
2006-04-13 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
EP2002003B1
(en)
|
2005-05-27 |
2015-12-30 |
Ospedale San Raffaele S.r.l. |
Gene vector comprising mi-rna
|
JP2009505680A
(ja)
|
2005-08-31 |
2009-02-12 |
ジェンベク、インコーポレイティッド |
アデノウイルスベクターに基づくマラリアワクチン
|
EP1951297A2
(en)
|
2005-11-10 |
2008-08-06 |
GenVec, Inc. |
Adenoviral vector-based foot-and-mouth disease vaccine
|
EP2035035A2
(en)
|
2006-06-09 |
2009-03-18 |
Novartis AG |
Immunogenic compositions for streptococcus agalactiae
|
BRPI0714981A2
(pt)
|
2006-07-28 |
2013-08-13 |
Sanofi Aventis |
composiÇço, mÉtodo para fazer a mesma a qual compreende um inibidor que inibe a atividade de uma proteÍna do complexo iii, um veÍculo e um membro da superfamÍlia da fator de necrose de tumor, mÉtodo para conduzir um ensaio para determinar se um composto É um inibidor de atividade de supressço de tnf de uma proteÍna do complexo iii e uso de um composto
|
PL2068922T3
(pl)
|
2006-10-19 |
2012-11-30 |
Csl Ltd |
Przeciwciała anty-IL-13R alfa1 i ich zastosowania
|
DK2068921T3
(da)
|
2006-10-19 |
2014-09-15 |
Csl Ltd |
Antistof-antagonister med høj affinitet af interleukin-13-receptor alpha 1
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
KR20090128494A
(ko)
|
2007-03-24 |
2009-12-15 |
겐자임 코포레이션 |
인간 아포리포프로틴 b에 상보적인 안티센스 올리고뉴클레오타이드 투여
|
CN101067139B
(zh)
*
|
2007-05-14 |
2010-05-26 |
清华大学深圳研究生院 |
一种RNAi载体及其应用
|
CN101619324B
(zh)
*
|
2008-07-01 |
2013-06-26 |
中国疾病预防控制中心病毒病预防控制所 |
复制缺陷型重组腺病毒Ad41载体系统及其应用
|
WO2010045659A1
(en)
|
2008-10-17 |
2010-04-22 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
RU2478396C2
(ru)
|
2008-11-05 |
2013-04-10 |
ВАЙЕТ ЭлЭлСи |
МНОГОКОМПОНЕНТНАЯ ИММУНОГЕННАЯ КОМПОЗИЦИЯ ДЛЯ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЯ, ВЫЗВАННОГО β-ГЕМОЛИТИЧЕСКИМИ СТРЕПТОКОККАМИ (БГС)
|
EP3115063A3
(en)
|
2008-12-03 |
2017-04-19 |
The John Hopkins University |
Galectin-3 and annexin-a2 as immunological target
|
EP2370582B1
(en)
*
|
2008-12-04 |
2017-05-10 |
CuRNA, Inc. |
Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
WO2011047316A1
(en)
|
2009-10-16 |
2011-04-21 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
CA2779632C
(en)
|
2009-11-09 |
2019-08-20 |
Jason Gall |
Simian adenovirus and methods of use
|
EP2547362B1
(en)
|
2010-03-17 |
2021-08-25 |
Cornell University |
Disrupted adenovirus-based vaccine against drugs of abuse
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
ES2639035T3
(es)
|
2010-08-23 |
2017-10-25 |
Wyeth Llc |
Formulaciones estables de antígenos rLP2086 de Neisseria meningitidis
|
RU2546873C2
(ru)
|
2010-09-10 |
2015-04-10 |
УАЙТ ЭлЭлСи |
Нелипидизированные варианты антигенов neisseria meningitidis orf2086
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
EP2654786B1
(en)
|
2010-12-20 |
2019-02-20 |
GenVec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
WO2012135549A2
(en)
|
2011-03-29 |
2012-10-04 |
Dynavax Technologies Corporation |
Tlr8 transgenic animals
|
CN102240405A
(zh)
*
|
2011-05-09 |
2011-11-16 |
上海市第十人民医院 |
ApoA-Ⅰmilano基因药物
|
WO2012162428A1
(en)
|
2011-05-23 |
2012-11-29 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Prime-boost vaccination for viral infection
|
US9233153B2
(en)
|
2011-10-05 |
2016-01-12 |
Genvec, Inc. |
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
|
WO2013052859A2
(en)
|
2011-10-05 |
2013-04-11 |
Genvec, Inc. |
Adenoviral vector-based respiratory syncytial virus (rsv) vaccine
|
BR112014008249B1
(pt)
|
2011-10-05 |
2022-03-15 |
Genvec Inc |
Adenovírus ou vetor adenoviral e composição com os mesmos
|
BR112014008284A2
(pt)
|
2011-10-05 |
2020-10-27 |
Genvec Inc. |
adenovirus (gorilla) simian ou vetores adenovirais e métodos de uso
|
RU2619184C2
(ru)
*
|
2011-12-28 |
2017-05-12 |
Ниппон Синяку Ко., Лтд. |
Антисмысловые нуклеиновые кислоты
|
US20150157700A1
(en)
|
2012-02-02 |
2015-06-11 |
GanVec, Inc. |
Adenoviral vector-based malaria vaccine
|
RU2491097C1
(ru)
*
|
2012-02-16 |
2013-08-27 |
Общество с ограниченной ответственностью "НТфарма" |
Фармацевтическая композиция и способ терапии нейродегенеративных заболеваний, в частности бокового амиотрофического склероза
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
AU2013229063B2
(en)
|
2012-03-09 |
2016-10-06 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
EP2855669B1
(en)
|
2012-05-29 |
2018-10-10 |
GenVec, Inc. |
Modified serotype 28 adenoviral vectors
|
EP2855511B1
(en)
|
2012-05-29 |
2019-07-24 |
GenVec, Inc. |
Herpes simplex virus vaccine
|
WO2014107739A1
(en)
|
2013-01-07 |
2014-07-10 |
Eleven Biotherapeutics, Inc. |
Antibodies against pcsk9
|
EP2964665B1
(en)
|
2013-03-08 |
2018-08-01 |
Pfizer Inc |
Immunogenic fusion polypeptides
|
EP2968613B1
(en)
|
2013-03-11 |
2019-09-11 |
University of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for occular inflammation
|
KR20210002757A
(ko)
|
2013-09-08 |
2021-01-08 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
CN105636981B
(zh)
*
|
2013-09-12 |
2020-11-06 |
生物马林药物股份有限公司 |
腺相关病毒因子viii载体
|
EP3372236A1
(en)
|
2013-10-25 |
2018-09-12 |
PsiOxus Therapeutics Limited |
Oncolytic adenoviruses armed with heterologous genes
|
WO2015127094A1
(en)
|
2014-02-19 |
2015-08-27 |
University Of Florida Research Foundation, Inc. |
Delivery of nrf2 as therapy for protection against reactive oxygen species
|
WO2016037154A1
(en)
|
2014-09-04 |
2016-03-10 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Recombinant hiv-1 envelope proteins and their use
|
US10420834B2
(en)
|
2014-12-24 |
2019-09-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant metapneumovirus F proteins and their use
|
CN107406835A
(zh)
|
2015-01-20 |
2017-11-28 |
美利坚合众国,由健康及人类服务部部长代表 |
表达嵌合rsv/bpiv3f蛋白的重组人/牛副流感病毒3(b/hpiv3)及其用途
|
US20180008727A1
(en)
|
2015-01-30 |
2018-01-11 |
The Regents Of The University Of California |
Spinal subpial gene delivery system
|
RU2723045C2
(ru)
|
2015-02-19 |
2020-06-08 |
Пфайзер Инк. |
Композиции neisseria meningitidis и способы их получения
|
EP3261665A1
(en)
|
2015-02-24 |
2018-01-03 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
|
AU2016256582B2
(en)
|
2015-04-30 |
2020-10-29 |
Akamis Bio Limited |
Oncolytic adenovirus encoding a B7 protein
|
WO2016200997A1
(en)
|
2015-06-10 |
2016-12-15 |
America Gene Technologies International, Inc. |
Non-integrating viral delivery system and methods of use thereof
|
EP3364985A4
(en)
|
2015-10-19 |
2019-03-27 |
University Of Maryland, Baltimore |
METHOD FOR GENERATING MANIPULATED DENDRITIC CELL LINES FROM HUMAN PRIMARY BLOOD
|
IL260027B
(en)
|
2015-12-17 |
2022-07-01 |
Psioxus Therapeutics Ltd |
A group b adenovirus that encodes an anti-tcr–complex antibody or particle
|
IL279520B2
(en)
|
2016-01-15 |
2023-03-01 |
American Gene Tech Int Inc |
Methods and preparations for the activation of gamma-delta t cells
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
JP7153332B2
(ja)
|
2016-02-08 |
2022-10-14 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
Hivワクチン接種および免疫療法
|
WO2017139392A1
(en)
|
2016-02-08 |
2017-08-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant hiv-1 envelope proteins and their use
|
JP7017247B2
(ja)
|
2016-03-09 |
2022-02-08 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
がんを処置するための組み合わせベクターおよび方法
|
WO2017156272A1
(en)
|
2016-03-09 |
2017-09-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant hiv-1 envelope proteins and their use
|
AU2017241534A1
(en)
|
2016-03-28 |
2018-10-04 |
The Regents Of The University Of California |
Method and composition for treating neuronal hyper-excitability
|
US11560412B2
(en)
|
2016-04-01 |
2023-01-24 |
University Of Maryland, Baltimore |
Compositions comprising GRIM-19 therapeutics and methods of use
|
CA2971303A1
(en)
*
|
2016-06-21 |
2017-12-21 |
Bamboo Therapeutics, Inc. |
Optimized mini-dystrophin genes and expression cassettes and their use
|
IL300730A
(en)
|
2016-07-08 |
2023-04-01 |
American Gene Tech Int Inc |
Pre-HIV vaccine and immunotherapy
|
WO2018017882A1
(en)
|
2016-07-21 |
2018-01-25 |
American Gene Technologies International Inc. |
Viral vectors for treating parkinson's disease
|
GB201713765D0
(en)
|
2017-08-28 |
2017-10-11 |
Psioxus Therapeutics Ltd |
Modified adenovirus
|
NZ751014A
(en)
|
2016-09-20 |
2023-03-31 |
Boehringer Ingelheim Vetmedica Gmbh |
New ehv insertion site orf70
|
EP3515480A1
(en)
|
2016-09-20 |
2019-07-31 |
Boehringer Ingelheim Vetmedica GmbH |
New swine influenza vaccine
|
CN109790550B
(zh)
|
2016-09-20 |
2024-02-09 |
勃林格殷格翰动物保健有限公司 |
新颖的启动子
|
EA201990718A1
(ru)
|
2016-09-20 |
2019-10-31 |
|
Векторы аденовируса собачьих
|
WO2018064523A1
(en)
|
2016-09-30 |
2018-04-05 |
Genvec, Inc. |
Adenovectors for delivery of therapeutic genetic material into t cells
|
WO2018067582A2
(en)
|
2016-10-03 |
2018-04-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv-1 env fusion peptide immunogens and their use
|
WO2018081318A1
(en)
|
2016-10-25 |
2018-05-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion coronavirus spike proteins and their use
|
US11147249B2
(en)
|
2016-12-08 |
2021-10-19 |
Alector Llc |
Siglec transgenic mice and methods of use thereof
|
EP3554538A2
(en)
|
2016-12-16 |
2019-10-23 |
Institute for Research in Biomedicine |
Novel recombinant prefusion rsv f proteins and uses thereof
|
IL303108B1
(en)
|
2017-01-31 |
2024-03-01 |
Pfizer |
NEISSERIA MENINGITIDIS preparations and methods therefor
|
EP3600405A1
(en)
|
2017-03-24 |
2020-02-05 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Glycan-masked engineered outer domains of hiv-1 gp120 and their use
|
CA3057142A1
(en)
|
2017-04-03 |
2018-10-11 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
CA3077426A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
WO2019079337A1
(en)
|
2017-10-16 |
2019-04-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
US11470827B2
(en)
|
2017-12-12 |
2022-10-18 |
Alector Llc |
Transgenic mice expressing human TREM proteins and methods of use thereof
|
AU2019231652A1
(en)
|
2018-03-06 |
2020-10-01 |
Precigen, Inc. |
Hepatitis B vaccines and uses of the same
|
US20210361318A1
(en)
|
2018-07-02 |
2021-11-25 |
Voyager Therapeutics, Inc. |
Cannula system and use thereof
|
JP2021529513A
(ja)
|
2018-07-02 |
2021-11-04 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
筋萎縮性側索硬化症および脊髄に関連する障害の治療
|
CA3117390A1
(en)
|
2018-10-22 |
2020-04-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant gp120 protein with v1-loop deletion
|
CN110714027A
(zh)
*
|
2019-10-28 |
2020-01-21 |
嘉铭(固安)生物科技有限公司 |
一种表达质粒、用于包装二代腺病毒的细胞株及其应用
|
JP2023513693A
(ja)
|
2020-02-11 |
2023-04-03 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
SARS-CoV-2ワクチン
|
US11213482B1
(en)
|
2020-03-05 |
2022-01-04 |
University of Pittsburgh—Of the Commonwealth System of Higher Educat |
SARS-CoV-2 subunit vaccine and microneedle array delivery system
|
KR20220150353A
(ko)
|
2020-03-05 |
2022-11-10 |
네오티엑스 테라퓨틱스 엘티디. |
면역 세포를 사용하여 암을 치료하기 위한 방법 및 조성물
|
US11773391B2
(en)
|
2020-04-01 |
2023-10-03 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19
|
EP4142785A2
(en)
|
2020-04-29 |
2023-03-08 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Recombinant human metapneumovirus f proteins and their use
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
WO2022035860A2
(en)
|
2020-08-10 |
2022-02-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Replication-competent adenovirus type 4-hiv env vaccines and their use
|
WO2022232648A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion-stabilized lassa virus glycoprotein complex and its use
|
CA3217862A1
(en)
|
2021-05-05 |
2022-11-10 |
Radius Pharmaceuticals, Inc. |
Animal model having homologous recombination of mouse pth1 receptor
|
AU2022323509A1
(en)
|
2021-08-03 |
2024-02-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infection
|
US20230277600A1
(en)
|
2021-10-20 |
2023-09-07 |
University Of Rochester |
Treatment Of Age-Related White Matter Loss By Competitive Replacement Of Glial Cells
|
WO2023081633A1
(en)
|
2021-11-02 |
2023-05-11 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
WO2023091696A1
(en)
|
2021-11-19 |
2023-05-25 |
Christiana Care Gene Editing Institute, Inc. |
Adenovirus delivery system for cancer treatment
|
WO2023192835A1
(en)
|
2022-03-27 |
2023-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Base-covered hiv-1 envelope ectodomains and their use
|
WO2023196898A1
(en)
|
2022-04-07 |
2023-10-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Beta globin mimetic peptides and their use
|